Tesla
TSLA
Taiwan Semiconductor
TSM
Meta Platforms
META
4
Amazon
AMZN
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 31.940
- +0.400+1.27%
Trading May 9 09:38 ET
1.79BMarket Cap28.83P/E (TTM)
31.990High31.215Low8.70KVolume31.540Open31.540Pre Close275.28KTurnover0.02%Turnover Ratio24.20P/E (Static)55.99MShares40.28052wk High1.74P/B1.55BFloat Cap25.53052wk Low--Dividend TTM48.66MShs Float61.250Historical High--Div YieldTTM2.46%Amplitude4.300Historical Low31.641Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
EPS
According to the latest financial report of Supernus Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Supernus Pharmaceuticals's free cash flow? The latest report shows it as 30.27M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Supernus Pharmaceuticals shows that the company's current ratio is 2.44, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Supernus Pharmaceuticals, the quick ratio is 2.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Supernus Pharmaceuticals? The latest ROE figure is -1.14%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Supernus Pharmaceuticals, the total asset return on investment (ROA) is -0.87%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Supernus Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 89.48%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Supernus Pharmaceuticals, the net profit margin is -7.89%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call